Chiltern, a leading global clinical research organization (CRO), recently announced the acquisition of Clinical Trial Management Services, Inc. (CTMS) a Bristol, Tennessee based CRO offering high quality services throughout the United States. From February 2008 the combined operation will be known exclusively as ‘Chiltern’.
Read More at PharmaceuticalOnline…
Related posts:
- Beale Joins Zurich as Merger/Acquisition-Transformation Management Head
- Leading Independent Wealth Management Firms Merge
- Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based …
- Volkswagen CEO Announces New Executive Appointments and Brand Management Restructuring
- Kalido Customer Nationwide Wins Information Management Technology Leadership Award from Ventana Research